Program Schedule
Toggle navigation
Welcome
All sessions are noted in Eastern Time Zone. Please adjust to your time zone accordingly
Full Program
11/2/2021
11/3/2021
11/4/2021
11/5/2021
Thursday
November 4, 2021
8:30 AM - 10:00 AM ET
300 - New Drug Update 2021: What’s Hot and What’s Not
Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, Adult/Family Nurse Practitioner, Wright & Associates Family Healthcare, Amherst, NH
×
300 - New Drug Update 2021: What’s Hot and What’s Not
CE Credit: 1.5; Rx Credit: 1.5
Keeping up with new medications, particularly given the plethora of direct-to-consumer advertising, is one of the true challenges of primary care. Ms. Wright will focus on the top new, widely used medications, including their appropriate uses, adverse effects, and drug interactions.
Learning Outcomes/Objectives:
Identify 10 – 20 new medications.
Discuss the use, side effects, drug-drug interactions, and benefits of each of the medications.
10:00 AM - 10:30 AM ET
301 - Exhibitor Showcase and Poster Sessions
Check out the Exhibitor Showcase and Poster Sessions during this time.
10:30 AM - 12:00 PM ET
302 - When What's on your Plate Makes you Ill: Food Allergy and Intolerance Deciphered
Ellen Karlin, MMSc, RDN, LDN, FADA, Nutrition Consultant, Private Practice
×
302 - When What's on your Plate Makes you Ill: Food Allergy and Intolerance Deciphered
CE Credit: 1.5; Rx Credit: 0
Food allergies and intolerances are growing and becoming serious public health concerns requiring significantly increased attention from nurse practitioners. This course will cover the nutritional management of food allergy, Celiac Disease, and irritable bowel syndrome. In addition, this session includes practical advice that you can share with your patients for food allergy prevention; based on the most recent guidance from the Dietary Guidelines for Americans, the American Academy of Allergy, Asthma, and Immunology and the American College of Allergy, Asthma, and Immunology.
Learning Outcomes/Objectives:
Identify the symptoms associated with food allergy, intolerance, and irritable bowel syndrome.
Delineate the challenges addressing the nutritional needs of the food allergy community.
Describe the paradigm shift in infant feeding guidelines for food allergy prevention.
10:30 AM - 12:00 PM ET
303 - Acneiform Skin Eruptions
Margaret Bobonich, DNP, FNP-C, DCNP, FAANP, Assistant Professor, Case Western Reserve University, School of Medicine and Frances Payne Bolton School of Nursing, University Hospitals Case Medical Center, Department of Dermatology, Cleveland, OH
×
303 - Acneiform Skin Eruptions
CE Credit: 1.5; Rx Credit: 1.5
We’ll discuss the most common acneiform skin eruptions in this presentation including acne (and beyond), rosacea seborrheic dermatitis, folliculitis, and perioral dermatitis.
Learning Outcomes/Objectives:
Review key morphology for acneiform eruptions.
Discuss distinguishing characteristic for differential diagnoses of acneiform skin eruptions.
Discuss important concepts in selecting appropriate pharmacotherapy for acnieform dermatoses.
10:30 AM - 12:00 PM ET
304 - Acute/Urgent/Emergency Care: Managing Non-Diabetes Endocrine Emergencies
Christine Kessler, MN, ANP-BC, CNS, BC-ADM, FAANP, Founder, Metabolic Medicine Associates, King George, VA
×
304 - Acute/Urgent/Emergency Care: Managing Non-Diabetes Endocrine Emergencies
CE Credit: 1.5; Rx Credit: 1.5
They are common, confusing, and often mimic other disorders—but can quickly evolve into a medical emergency, i.e.: acute endocrinopathies. A delay in treatment aimed at the precise hormonal disorder is almost always lethal. Using real acute care case studies, this lively session will provide attendees with expert endocrinology tips on how to effectively identify, evaluate, and provide urgent interventions for selected non-diabetic endocrine emergencies, such as thyroid storm, myxedema coma, acute hypopituitarism, and hypercalcemia.
Learning Outcomes/Objectives:
Identify risk factors that contribute to the development of thyroid, pituitary & hypercalcemic emergencies.
Discuss clinical and laboratory assessment findings in selected thyroid, pituitary & hypercalcemic emergencies.
Discuss treatment priorities for selected thyroid, pituitary & hypercalcemic emergencies.
12:00 PM - 1:30 PM ET
305 - Exhibitor Showcase and Posters
CE/Rx will not be offered for this sponsored event.
1:30 PM - 3:00 PM ET
306 - Laboratory Diagnosis: Challenging Cases
Margaret A. Fitzgerald, DNP, FNP-BC, NP-C, FAANP, CSP, FAAN, DCC, FNAP, Founder/Family NP, Fitzgerald Health Education Associates, LLC, Greater Lawrence Family Health Center, Lawrence, MA
×
306 - Laboratory Diagnosis: Challenging Cases
CE Credit: 1.5; Rx Credit: 1
Laboratory testing often plays a key role in formulating and/or refining the differential diagnosis. Dr. Margaret Fitzgerald presents challenging cases to help you refine your expertise in ordering laboratory tests and analyzing the results. Lab data discussed in this course include hepatic enzymes and hematologic and renal parameters.
Learning Outcomes/Objectives:
Discuss formulating and refining differential diagnosis.
Refine expertise in ordering laboratory tests.
1:30 PM - 3:00 PM ET
307 - Update on Osteoporosis and Fracture Prevention in Women and Men
Nancy R. Berman, MSN, ANP-BC, NCMP, FAANP, Adult Nurse Practitioner, Millennium Affiliated Physicians, Division of Michigan Healthcare Professionals, Farmington Hills, MI
×
307 - Update on Osteoporosis and Fracture Prevention in Women and Men
CE Credit: 1.5; Rx Credit: 1
This session will provide information regarding the identification of women and men at risk for fracture based on bone densitometry and their 10-year fracture risk using the FRAX calculation. Pharmacologic therapies will be reviewed including patient selection for first line therapies and therapies for patients at extremely high risk and drug risks and benefits. Current controversies will be discussed including long-term use of bisphosphonates, adverse events including osteonecrosis of the jaw (ONJ) and atypical subtrochanteric femur fractures and drug holidays. Concerns about discontinuation of rank ligand inhibitors and the rapid increase in vertebral fractures will be discussed. Treatment of patients at high risk due to therapy such as aromatase inhibitors and androgen deprivation therapy will be presented. Case studies will be used to provide real clinical scenarios.
Learning Outcomes/Objectives:
Discuss the diagnosis of osteoporosis, low bone mass and high risk for fracture.
Discuss current pharmacologic options for fracture prevention including bisphosphonates, rank ligand inhibitors, anabolic agents and an anti-sclerostin agent.
Discuss appropriate clinical management with case studies.
1:30 PM - 3:00 PM ET
308 - Acute/Emergency Care: Marijuana and its Cardiac Implications
Andrea Efre, DNP, ARNP, ANP-BC, Healthcare Education Consultants, Tampa, FL
×
308 - Acute/Emergency Care: Marijuana and its Cardiac Implications
CE Credit: 1.5; Rx Credit: 1.5
Marijuana has been used by many cultures for centuries, yet there is still much to be learned about its therapeutic uses and adverse effects. The lack of phase III clinical trials has prevented the medical community from understanding the efficacy, effectiveness, and safety of marijuana as a medication. Yet the legalization of recreational marijuana in various states has forced healthcare to consider the complex effects of marijuana on the body. This talk will provide an overview of marijuana use (both medical and recreational) and focus on its cardiac implications.
Learning Outcomes/Objectives:
Discuss the therapeutic and recreational uses of marijuana.
Define the action of cannabinoids, specifically the two main cannabinoids: tetrahydrocannabinol (THC) and cannabidiol (CBD).
Discuss appropriate clinical management with case studies.
Identify the effects and adverse effects of marijuana on the cardiovascular system.
3:00 PM - 3:30 PM ET
309 - Exhibit Showcase and Poster Session
Check out the Exhibitor Showcase and Posters during this time.
3:30 PM - 5:00 PM ET
310 - Latest in Treatment Options for Vaping and Tobacco Use: Successful Methods for Teens and Adults
Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, Adult/Family Nurse Practitioner, Wright & Associates Family Healthcare, Amherst, NH
×
310 - Latest in Treatment Options for Vaping and Tobacco Use: Successful Methods for Teens and Adults
CE Credit: 1.5; Rx Credit: 1.5
Approximately 13.7% of adults in the United States smoke cigarettes with another 27.5% of all teens having vaped or used an E-cig in the past 30 days. Vaping and tobacco use are associated with significant morbidity and mortality. It is essential that APRNs assess smoking status every visit and counsel patients about the importance of cessation. Strategies for successful vaping and tobacco use cessation practices in primary and specialty care will be discussed.
Learning Outcomes/Objectives:
Discuss statistics regarding cigarette, tobacco, and vaping.
Identify strategies to assist the individual with quitting smoking, vaping, tobacco use.
Review benefits and risks of the various pharmacologic practices.
3:30 PM - 5:00 PM ET
311 - Beyond LDL-C Lowering: Safety and Tolerability of Statin Therapy
Joyce L. Ross, MSN, CRNP, CS, FNLA, FPCNA, Diplomate Accreditation Council for Clinical Lipidology, Consultative Education Specialist, Cardiovascular Risk Intervention, Clinical Associate University of Pennsylvania Health System, Philadelphia, PA
×
311 - Beyond LDL-C Lowering: Safety and Tolerability of Statin Therapy
CE Credit: 1.5; Rx Credit: 1.5
Statin therapy is the medication of choice in the treatment of dyslipidemia. Many questions arise regarding the best statin for an individual patient, especially those related to cognition, influences with diabetes, statin intolerance, liver and muscle toxicity, and potential interactions with other medications. This session will address those issues separating myth from reality when it comes to these potential problems. Case studies will be presented related to guidelines and best practices.
Learning Outcomes/Objectives:
Understand that statin therapy is the mainstay for intervention in the management of dyslipidemia.
Recall effects and myths of statin therapy regarding cognition, diabetes, liver, muscle tolerability, and interactions with other drugs.
Individualize statin therapy based on safety and tolerability considerations.
3:30 PM - 5:00 PM ET
312 - Acute/Urgent/Emergency Care: Bugs vs Drugs: Gotta Kill Them All
Jonathan Van Cleve, PharmD, BCCCP, Critical Care Clinical Pharmacist, Lovelace Medical Center, Albuquerque, NM
×
312 - Acute/Urgent/Emergency Care: Bugs vs Drugs: Gotta Kill Them All
CE Credit: 1.5; Rx Credit: 1.5
Itchy nights, growing warts, blistering acne, balding scalps, crusty growths, and even bugs on and under the skin can create headaches and stress for parents, providers, and the children that come for help. Additionally, the presentations are not always textbook perfect: What are the differentials to a reddish round patch? Is yellow crusting always impetigo? Are there danger signs we should be aware of? This fast-paced presentation will include many photos and illustrations to help our primary care providers improve their assessment and treatment skills.
Learning Outcomes/Objectives:
Discuss differential diagnosis of common dermatologic conditions.
Identify danger signs.
Improve assessment skills and treatment regimes.
